Cargando…
Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report
Venetoclax with high‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia.
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044374/ https://www.ncbi.nlm.nih.gov/pubmed/32128171 http://dx.doi.org/10.1002/ccr3.2580 |
| _version_ | 1783501557259567104 |
|---|---|
| author | Beziat, Guillaume Gauthier, Martin Protin, Caroline Oberic, Lucie Lerebours, Fleur Carlier, Jasmine Ysebaert, Loïc |
| author_facet | Beziat, Guillaume Gauthier, Martin Protin, Caroline Oberic, Lucie Lerebours, Fleur Carlier, Jasmine Ysebaert, Loïc |
| author_sort | Beziat, Guillaume |
| collection | PubMed |
| description | Venetoclax with high‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia. |
| format | Online Article Text |
| id | pubmed-7044374 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70443742020-03-03 Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report Beziat, Guillaume Gauthier, Martin Protin, Caroline Oberic, Lucie Lerebours, Fleur Carlier, Jasmine Ysebaert, Loïc Clin Case Rep Case Reports Venetoclax with high‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia. John Wiley and Sons Inc. 2020-01-10 /pmc/articles/PMC7044374/ /pubmed/32128171 http://dx.doi.org/10.1002/ccr3.2580 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Case Reports Beziat, Guillaume Gauthier, Martin Protin, Caroline Oberic, Lucie Lerebours, Fleur Carlier, Jasmine Ysebaert, Loïc Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report |
| title | Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report |
| title_full | Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report |
| title_fullStr | Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report |
| title_full_unstemmed | Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report |
| title_short | Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report |
| title_sort | venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: a case report |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044374/ https://www.ncbi.nlm.nih.gov/pubmed/32128171 http://dx.doi.org/10.1002/ccr3.2580 |
| work_keys_str_mv | AT beziatguillaume venetoclaxwithhighdosemethotrexateandrituximabseemeffectiveandwelltoleratedinthetreatmentofcentralnervoussysteminvolvementofchroniclymphocyticleukemiaacasereport AT gauthiermartin venetoclaxwithhighdosemethotrexateandrituximabseemeffectiveandwelltoleratedinthetreatmentofcentralnervoussysteminvolvementofchroniclymphocyticleukemiaacasereport AT protincaroline venetoclaxwithhighdosemethotrexateandrituximabseemeffectiveandwelltoleratedinthetreatmentofcentralnervoussysteminvolvementofchroniclymphocyticleukemiaacasereport AT obericlucie venetoclaxwithhighdosemethotrexateandrituximabseemeffectiveandwelltoleratedinthetreatmentofcentralnervoussysteminvolvementofchroniclymphocyticleukemiaacasereport AT lereboursfleur venetoclaxwithhighdosemethotrexateandrituximabseemeffectiveandwelltoleratedinthetreatmentofcentralnervoussysteminvolvementofchroniclymphocyticleukemiaacasereport AT carlierjasmine venetoclaxwithhighdosemethotrexateandrituximabseemeffectiveandwelltoleratedinthetreatmentofcentralnervoussysteminvolvementofchroniclymphocyticleukemiaacasereport AT ysebaertloic venetoclaxwithhighdosemethotrexateandrituximabseemeffectiveandwelltoleratedinthetreatmentofcentralnervoussysteminvolvementofchroniclymphocyticleukemiaacasereport |